Hyderabad: Pharma major Dr Reddy’s Laboratories Ltd completed the phase-3 trials of Russia’s COVID-19 vaccine – Sputnik V.
“We have completed the dosing for Phase-3,” a spokesperson of Dr Reddy’s Laboratories Ltd told BusinessLine. It was conducted with around 1,500 subjects and the results of the trial are expected to be out in early April.
The vaccine has been applied for emergency use in India but the government has sought phase-3 trial results. If approved, it will be the 3rd COVID-19 vaccine in India, after Covishield and Covaxin.
Dr. Reddy’s signed up with Russian Direct Investment Fund (RDIF) to conduct clinical trials of the vaccine and distribute it here, back in September 2020.
The vaccine has been developed by the Gamaleya National Research Institute of Epidemiology and Microbiology. It was the world’s first registered vaccine against COVID-19.
The company claims an efficacy of 91.6 per cent and has been authorised in 26 countries along with 2 million people.
New York: Ahead of Christmas, stranded NASA astronauts Sunita Williams and Butch Wilmore turned Santa…
Hyderabad: There’s no respite for BRS leader KT Rama Rao (KTR) in the case linked…
Sambalpur: The Indian Institute of Management (IIM) at Sambalpur in Odisha has announced changes in…
Mumbai: Arjun Kapoor, who broke up with girlfriend Malaika Arora, impressed movie buffs and critics…
Mumbai: ‘Citadel: Honey Bunny’ actor Varun Dhawan, who has been in the industry for a…
New Delhi: Delhi Police on Friday transferred the FIR filed against Congress leader Rahul Gandhi…
This website uses cookies.